Live feed
Filing
SC 13D
SC 13D0001437749-16-026839·NovaBay Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
NOVABAY PHARMACEUTICALS INC
Security class unavailable · CUSIP: 66987P201
Event date: 2016-02-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 24.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-16-026839
- Form type
- SC 13D
- Filer
- NovaBay Pharmaceuticals, Inc.
- CIK
- CIK 1389545
- Filed
- Mar 04, 2016
- Reporting period
- Feb 24, 2016
- Description
- Schedule 13D beneficial ownership